MYD88 and liver cancer: Recently, we also found that MyD88 in HSCs/myofibroblasts promoted the progress of DEN/CCl4-induced fibrosis-related HCC via CCL20 secretion and promoted the aerobic glycolysis of liver cancer cells [28].